HCM Q3 2020 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$61M+22.8% YoY

Gross Profit

-$42M-69.7% margin

Operating Income

-$59M-97.8% margin

Net Income

-$38M-62.7% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+9.8%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$724M

Total Liabilities

$205M

Stockholders' Equity

$484M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$49M	+22.8%
Gross Profit	-$42M	-$20M	-108.0%
Operating Income	-$59M	-$36M	-64.9%
Net Income	-$38M	-$31M	-22.3%